Reviewing Sintx Technologies (NASDAQ:SINT) and Terumo (OTCMKTS:TRUMY)

Sintx Technologies (NASDAQ:SINT) and Terumo (OTCMKTS:TRUMY) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.

Valuation and Earnings

This table compares Sintx Technologies and Terumo”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02 million	11.49	-$10.36 million	($4.91)	-0.32
Terumo	$7.52 billion	3.10	$897.03 million	$0.71	22.23

Terumo has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Terumo, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. 8.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Sintx Technologies and Terumo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-281.91%	-309.86%	-101.90%
Terumo	13.83%	10.44%	7.34%

Analyst Recommendations

This is a breakdown of recent ratings for Sintx Technologies and Terumo, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1	0	3	0	2.50
Terumo	0	0	0	2	4.00

Sintx Technologies presently has a consensus price target of $9.50, suggesting a potential upside of 512.90%. Given Sintx Technologies’ higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than Terumo.

Summary

Terumo beats Sintx Technologies on 8 of the 13 factors compared between the two stocks.

About Sintx Technologies

SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.